Editorial comment on: Impact of multimodal treatment on survival in patients with metastatic urothelial cancer

Affiliations

Comment

Aristotle Bamias. Eur Urol. 2007 Oct.

. 2007 Oct;52(4):1113-4.

doi: 10.1016/j.eururo.2007.02.053.

¹ Department of Clinical Therapeutics, University of Athens, Medical School, Athens, Greece. abamias@med.uoa.gr

No abstract available

Comment on

Impact of multimodal treatment on survival in patients with metastatic urothelial cancer.
Abe T, Shinohara N, Harabayashi T, Sazawa A, Maruyama S, Suzuki S, Nonomura K. Abe T, et al. Eur Urol. 2007 Oct;52(4):1106-13. doi: 10.1016/j.eururo.2007.02.052. Epub 2007 Mar 6. Eur Urol. 2007. PMID: 17367917

Impact of multimodal treatment on survival in patients with metastatic urothelial cancer.
Abe T, Shinohara N, Harabayashi T, Sazawa A, Maruyama S, Suzuki S, Nonomura K. Abe T, et al. Eur Urol. 2007 Oct;52(4):1106-13. doi: 10.1016/j.eururo.2007.02.052. Epub 2007 Mar 6. Eur Urol. 2007. PMID: 17367917
Systemic therapy for metastatic urothelial carcinoma.
Lin CC, Hsu CH, Pu YS, Vogelzang NJ. Lin CC, et al. BJU Int. 2008 Apr;101(7):795-803. doi: 10.1111/j.1464-410X.2007.07356.x. Epub 2007 Dec 5. BJU Int. 2008. PMID: 18070193 Review. No abstract available.
The evolving role of chemotherapy in advanced urothelial cancer.
Calabrò F, Sternberg CN. Calabrò F, et al. Curr Opin Support Palliat Care. 2007 Oct;1(3):180-6. doi: 10.1097/SPC.0b013e3282f1aad1. Curr Opin Support Palliat Care. 2007. PMID: 18685360 Review.
Treatment of metastatic urothelial cancer: opportunities for drug discovery and development.
Sonpavde G, Sternberg CN. Sonpavde G, et al. BJU Int. 2008 Nov;102(9 Pt B):1354-60. doi: 10.1111/j.1464-410X.2008.07982.x. BJU Int. 2008. PMID: 19035904 Review.
Predictive factors for response and prognostic factors for long-term survival in consecutive, single institution patients with locally advanced and/or metastatic transitional cell carcinoma following cisplatin-based chemotherapy.
Jessen C, Agerbaek M, Von Der Maase H. Jessen C, et al. Acta Oncol. 2009;48(3):411-7. doi: 10.1080/02841860802325932. Acta Oncol. 2009. PMID: 18798018 Clinical Trial.